Company / R&D per Share
Corbus Pharmaceuticals Holdings, Inc. R&D per Share History
FY2015-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$8.74
FY2022
5-year range
$0.47 / $8.74
FY2018-FY2022
Trend
+779.3%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share changed +779% YoY in FY2022, a notable deviation from the 7-year average annual change of +188%.
Based on SEC 10-K filings.
8.74 in FY2022 with a 5-year CAGR of +123.5%.
Improved from $1.39 to $8.74 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +117.5%
- 5-Year CAGR
- +123.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, r&d per share increased 779.3% year-over-year.
- Lowest r&d per share in the period was in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -12.48 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $8.74 | +779.3% |
| FY2021 | $0.99 | -28.3% |
| FY2020 | $1.39 | +63.2% |
| FY2019 | $0.85 | +81.3% |
| FY2018 | $0.47 | +199.1% |
| FY2017 | $0.16 | +0.0% |
| FY2016 | $0.16 | +223.5% |
| FY2015 | $0.05 | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026